Physician profile
Barbara Williams Leday
NPI 1437490208
$1,895.42
in general payments reported to CMS, 2019-2025
15 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $431 · 2022: $434 · 2023: $431 · 2024: $250 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $374.34 | 2022-2023 | Epclusa |
| Teva Pharmaceuticals USA, INC. | $235.36 | 2023-2024 | Uzedy |
| Astrazeneca Pharmaceuticals LP | $223.85 | 2021-2025 | Airsupra |
| Neurocrine Biosciences, INC. | $203.35 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $151.01 | 2022-2024 | Rexulti, Abilify Maintena |
| Axsome Therapeutics, INC. | $124.96 | 2025 | Auvelity |
| Abbvie INC. | $114.95 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $113.83 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.61 | 2025 | Jardiance |
| Glaxosmithkline, LLC. | $112.95 | 2021 | |
| Exact Sciences Corporation | $36.89 | 2023-2024 | Cologuard Collection Kit |
| Dexcom, INC. | $26.40 | 2023 | Dexcom G6 Transmitter |
| Recor Medical INC | $24.45 | 2024 | Paradise Renal Denervation System |
| Pfizer INC. | $22.39 | 2024 | |
| Insulet Corporation | $17.08 | 2024 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Leday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.